Print version ISSN 0066-782X
Arq. Bras. Cardiol. vol.98 no.4 São Paulo Apr. 2012 Epub Mar 08, 2012
Marina de Moraes Vasconcelos PetribúI; Poliana Coelho CabralI; Alcides da Silva DinizI; Pedro Israel Cabral de LiraI; Malaquias Batista FilhoII; Ilma Kruze Grande de ArrudaI
Federal de Pernambuco, Recife, PE - Brazil
IIInstituto Materno Infantil de Pernambuco, Recife, PE - Brazil
The accumulation of visceral fat is considered a major risk factor for cardiovascular
and metabolic diseases.
OBJECTIVE: To determine the prevalence of visceral obesity and to assess its association with cardiovascular risk factors in young women from the state of Pernambuco.
METHODS: Cross-sectional study carried out with data from the "III Health and Nutrition State Survey", involving women aged 25 to 36 years. The following variables were evaluated: body mass index (BMI), Waist Circumference (WC), waist-to-height ratio (WHtR), volume of visceral fat (VVF) estimated by a predictive equation, Systolic and Diastolic Blood Pressure (SBP, DBP), total cholesterol (TC), Triglycerides (TG), fasting glucose (FG).
RESULTS: A total of 517 women were evaluated, with a median age of 29 years (27-32) and prevalence of visceral obesity of 30.6%. BMI, SBP, DBP and TG were higher in the group with visceral obesity: BMI = 28.0 kg/m2 (25.0 to 21.4) vs. 23.9 kg/m2 (21.5 to 26.4) , SBP = 120.0 mmHg (110.0 to 130.0) vs. 112.0 mmHg (100.0 to 122.0), DBP = 74 mmHg (70-80) vs. 70 mmHg (63-80); TG = 156.0 mg / dL (115.0 to 203.2) vs. 131.0 mg / dL (104.0 to 161.0), respectively, p < 0.01. Age, SBP, DBP, TG and TC levels were significantly and positively correlated with the VVF: r = 0.171, 0.224, 0.163, 0.278, 0.124 respectively, p < 0.005.
CONCLUSION: A high prevalence of visceral obesity was observed, being statistically correlated with cardiovascular risk factors.
Keywords: Subcutaneous rat, abdominal; prevalence; risk factors; cardiovascular diseases; body mass index; blood pressure; dyslipidemias; women.
Abdominal obesity, considered a risk factor for several morbidities1, consists of two distinct fat compartments: subcutaneous and visceral fat2. Several authors have shown that visceral, but not subcutaneous fat, is associated with several deleterious effects, such as high levels of triglycerides (TG), low high-density lipoprotein (HDL-C), insulin sensitivity3,4, hyperglycemia, C4 peptide, metabolic syndrome3-5, endothelial dysfunction6, hepatic and muscle steatosis, low levels of peptin and adiponectin4, and smaller and denser low density lipoprotein (LDL)7. Thus, the accumulation of visceral fat is considered a major risk factor for cardiovascular (CVD) and metabolic diseases7.
Although the exact molecular mechanism responsible for this association is unknown, the effect may occur due to the anatomical location of fat within the abdomen or the differences in metabolic properties3.
Thus, the reduction of visceral fat can be a preventive measure for the metabolic syndrome and CVD7. The measurement of Visceral Adipose Tissue (VAT) has therefore particular implication on public health8 and the reliability of its measurement is of great clinical importance9.
Few studies have determined the prevalence of visceral obesity in different populations10-12, probably due to the limitations of radiological methods, capable of differentiating the components of abdominal fat in subcutaneous and visceral fat, in addition to the inability of anthropometric measurements to represent the VAT area particularly13. Computed tomography (CT), Magnetic Resonance Imaging (MRI) and ultrasonography (USG) have high cost, limited availability of equipment and submit the individuals undergoing assessment to radiation (CT)14,15, preventing their use for the assessment in large groups of individuals, precluding its use as a screening tool for the population16.
Therefore, this study aimed to determine the prevalence of visceral obesity in young women from the state of Pernambuco, Brazil, based on a predictive equation, and to evaluate the association of visceral fat with risk factors for CVD.
The present was a cross-sectional population-based study, based on data from the ""III Health and Nutrition State Survey", (PESN III)", held in urban and rural areas of Pernambuco between May and October 2006.
The present study involved adult females aged 25 to 36 years of age. To calculate the sample size, we considered the prevalence of visceral obesity of 28.7%11, an estimation error of 4% and a confidence level of 95%, totaling 491 individuals. The III PESN database contained 669 women aged 25 to 36 years; however, of these, 152 were excluded due to lack of clinical data, and thus a total of 517 women who had all the variables used in this study were enrolled. The III PESN adopted as exclusion criteria pregnant women and women with physical limitations that impaired the anthropometric measurements.
Height was measured using a portable stadiometer (Alturaexata Ltda.) with a precision of 1 mm. The subjects were positioned upright, barefoot, with upper limbs hanging on the sides of the body, and heels, back and head touching the wooden column. Weight was measured using a digital scale (Model MEA-03200/Plenna) with a capacity of 150 kg and 100-gram scale, with the individual barefoot and wearing light clothing. To ensure their accuracy, two weight and height measurements were obtained, and when the difference exceeded 0.5 cm in height and 100 g in weight, the measurement was repeated and the two closest measurements were written down, and the mean value was used.
Nutritional status was classified using weight and height measurements through the Body Mass Index (BMI), by adopting the cutoffs recommended by the World Health Organization (WHO), 199817.
Waist Circumference (WC) was measured in duplicate at the midpoint between the last rib and the iliac crest, with a tape measure, following the WHO protocol, 199818, and values > 80 cm were considered high18.
The Waist-to-Height Ratio (WHtR) was determined by dividing the WC (cm) by the height (cm) and the cutoff point adopted for discrimination of abdominal obesity and cardiovascular risk was > 0.5319.
The measurements of total cholesterol (TC), triglycerides (TG) and fasting glucose (FG) were measured in venous blood by cubital puncture after a 12-hour overnight fast. Plasma concentrations of TC and TG were determined by absorption photometry with enzymatic method. The reference values were those recommended by the III Brazilian Guidelines on Dyslipidemia20. The FG measurement was performed using the Accutrend GCT equipment, read immediately after venipuncture, and the cutoff points adopted were those recommended by the American Diabetics Association, 201021.
The diastolic and systolic blood pressures (SBP and DBP) were determined using a calibrated aneroid sphygmomanometer (Premium EC 0483), adopting the protocol and classification of the VI Brazilian Guidelines on Hypertension (2010)22.
The volume of visceral fat (VVF) was estimated using the predictive equation proposed by Petribú23 that uses as independent variables the WHtR and FG, as follows:
VVF = -130.941 + (198.673 x WHtR) + (1.185 x FG);
This equation, developed from a multiple regression analysis by adopting the USG as a reference standard, is capable of predicting the VVF in approximately 45%, with a standard error of estimate of ± 15.19 cm2. The validation was performed by comparing the VVF measured by the equation and measured by ultrasonography in a group of women not participating in the stage of development of the equation using the Student's t test for paired samples, with no statistically significant difference between the values (54.28 ± 9.79 vs. 53.36 ± 7.94, respectively, p = 0.760)23. At an additional step, to assess the agreement between the two methods, the Bland Altman was carried out and there was a good agreement, with a bias close to zero (Figure 1). A cutoff of 100 cm2 was adopted for the diagnosis of visceral obesity24.
The database was compiled using the Epi Info software release 6.04 (CDC/WHO, Atlanta, GE, USA), with double entry, and further use of the validation mode to check for any typing errors. For statistical analyses, we used the SPSS software, release 10.0 (SPSS Inc., Chicago, IL, USA). Continuous variables were tested according to the normal distribution using the Kolmogorov-Smirnov test. When they had a non-normal distribution, they were transformed to their natural logarithm and retested for normality (age, weight, SBP, DBP, FG, TG, TC, BMI, VVF). When they maintained the non-normal distribution (age, SBP, DBP, FG, TC), they were described as median and interquartile range and the non-parametric tests were applied.
The comparison between the medians was carried out by nonparametric Mann Whitney test. The association between continuous variables was performed by Spearman's linear correlation test. The significance level was set at 5% to reject the null hypothesis.
The III PESN research project was approved by the Research Ethics Committee in Humans of Instituto de Medicina Integral Professor Fernando Figueira (IMIP), on January 12, 2006 (Protocol No. 709/2006). Women who agreed to participate in the study signed an informed consent form.
This study was funded by the National Council for Scientific and Technological Development (CNPq) (Process No. 505540/2004-5 and 501989/2005-4), being a collaborative study of the following institutions: Universidade Federal de Pernambuco (UFPE), IMIP and Health Secretariat of the state of Pernambuco.
The women's median age was 29 years (CI: 27-32). In general, this was an overweight population according to BMI, in addition to a high concentration of abdominal fat, as shown by WC and WHtR. Regarding SBP and DBP, laboratory parameters (FG, TG and TC) and the VVF estimated by the predictive equation, the values corresponding to the mean or median were below the reference values (Table 1).
Regarding the nutritional status, there was a low prevalence of underweight and a high prevalence of overweight and obesity based on BMI. About 30% of the women had visceral obesity and more than half, abdominal obesity according to WC and WHtR (Table 2).
About 10% of the women had SBP and/or DBP alterations. The prevalence of hyperglycemia was close to 30%, while almost 40% had increased TG. Regarding the TC, only 13% had hypercholesterolemia (Table 3).
Table 4 shows the comparison between the medians of BMI, SBP, DBP, TG and TC in women with and without visceral obesity. With the exception of TC, all parameters were higher in the group with visceral obesity (p <0.002).
The correlations between SBP, DBP, TG and TC and VVF estimated from the equation are described in Figure 2.
All variables showed a positive and significant correlation with VVF, but such correlations were weak. Moreover, age also showed a significant and positive correlation with VVF (r = 0.171, p < 0.0001).
The population analyzed in this study was classified as overweight according to their mean BMI, in addition to showing mean values of WC and WHtR above the cutoff in the evaluation of abdominal obesity. Nevertheless, they had a mean VVF < 100 cm2. Similar data were observed by Piernas Sánchez et al11, who applied a predictive equation to a population of 230 women, mean age 39 ± 12 years and mean BMI of 29 ± 5 kg/m2, and observed that, despite being overweight, having high body fat percentage and high cardiovascular risk according to WC and WHtR, the women had subcutaneous, but not visceral fat. These authors stressed the fact that women tend to accumulate more subcutaneous fat in the abdominal region, which could explain these findings11.
Unlike the above, Onat et al25 found in their study, which also involved women classified as overweight with abdominal obesity according to the mean BMI and WC, respectively, a much higher mean of VVF than that of the present study (120.5 ± 58 cm2). It is noteworthy the fact that the study was conducted in a population with a mean age of 49 ± 8.7 years with a high prevalence of metabolic syndrome (34%)25. These authors emphasized the significant increase in VAT with age and a 42% higher mean in the group with metabolic syndrome25, which may explain the difference observed when compared with the present study, which involved younger women, less likely to have metabolic syndrome. In relation to the increase in the VVF according to age, these results were also described by Pascot et al26, who found a mean VVF of 63.7 ± 40.9 cm2 in young women (27.4 ± 7.5 years) and 116.1 ± 67.5 cm2 in middle-aged women (49.5 ± 5.3 years), with this difference being statistically significant. This study also showed a positive correlation between age and VVF.
Literature reports that the prevalence of abdominal obesity has increased over the last decade and now exceeds the prevalence of overall obesity, with rates of 61.3% in women27,28. Such evidence was also found in the present study, which found a prevalence of 17% of overall obesity and 62.9% of abdominal obesity according to the WC.
The prevalence of visceral obesity was lower than the abdominal obesity, which was expected, considering that the WC is more strongly associated with subcutaneous fat than with visceral fat, and that the aging process is associated with loss of subcutaneous fat and increased visceral fat29, i.e., the study population, consisting solely of young adults, probably has a higher amount of subcutaneous abdominal fat than visceral fat. Moreover, Pou et al29 called attention to the fact that, in their study, approximately one quarter of the obese individuals or with high WC did not have high VAT, while 10% of women and 20% of men with normal WC had high VAT, suggesting that there are misclassifications between the categories of clinical adiposity29.
The prevalence of visceral obesity found in this study was similar to that described by Piernas Sánchez et al11, who found a prevalence of 28.7% among women. Pou et al29, when assessing 3,348 participants of the Framingham Heart Study Offspring and Third Generation Cohort with a mean age of 52.2 ± 9.9 years, found a prevalence of visceral obesity of 44% in females. However, in addition to the fact that the population was older than that in the present study, the authors used a cutoff for the classification of different visceral obesity29 and this may have influenced the high prevalence observed.
In agreement with the findings of Tadokoro et al10, it was observed that the BMI values were higher in group with visceral obesity. This finding was also described by Pou et al29, who observed that the prevalence of VAT increased with the increasing BMI category.
When comparing the TG and TC levels between the groups with and without visceral obesity, there were statistically higher values in the first group only for TG. This finding can be explained by the fact that, with increasing VAT, free fatty acids are readily targeted to the liver for further production of glucose, TG, and very-low density lipoprotein (VLDL)30. Other studies also found higher serum TG levels in subjects with high VAT4,29,31. However, these studies found lower levels of HDL in these individuals4,29,31. A limitation of the present study was the fact that it did not assess cholesterol fractions (HDL, LDL and VLDL), as the fact that TC was not different between the two groups may be due to a possible decrease in HDL in the group with visceral obesity.
Tadokoro et al10 and Reyes et al31 did not observe any significant difference regarding TC values between the two groups.
Regarding blood pressure, SBP and DBP values were higher in the group with visceral obesity. However, this finding was not observed in other studies4,10,31,32. Romero-Corral et al6 draw attention to the fact that the visceral fat is associated with endothelial dysfunction, even in the absence of blood pressure alterations. One possible explanation for the increase in BP found in individuals with visceral obesity is the fact that visceral adipokines and cytokines may contribute to insulin resistance33. Hyperinsulinemia can elevate blood pressure through the sympathetic nervous system activation, the impairment of peripheral vasodilation, an increased response to angiotensin and increased renal reabsorption of sodium and water, with consequent volume overload34.
The VVF was positively correlated with multiple metabolic risk factors in this study (SBP, DBP, TG and TC). This finding was also observed by other authors32,35. Kotronen et al32 found a positive and significant correlation between visceral fat and levels of TG, SBP and DBP (r = 0.36, 0.28 and 0.24, respectively) and a negative one with HDL (r = -0.38). Hayes et al35 found, in severely obese women (BMI = 31-67 kg/m2), a significant positive correlation between intra-abdominal fat and SBP (r = 0.35), DBP (r = 0.31) and a negative one with HDL (r = -0.34). The correlation with the TG was close to statistical significance (r = 0.31, p = 0.054)35. Fox et al36, studying individuals with a mean age of 50 years from the Framingham Heart Study, found a significant association between SBP (r = 0.30), DBP (r = 0.28), FG (r = 0.34), TG (r = 0.46) and HDL (r = -0.35) with VAT in women.
In turn, Tadokoro et al10 found a significant and positive correlation between visceral fat and SBP and TG only in males, while the TC and DBP showed no significant correlation with visceral fat in both sexes. It was also observed a negative correlation between HDL and visceral fat in women, but this study was carried out with adolescents, with a mean age of approximately 15 years10, which may have contributed to these findings.
A positive fact of the present study was that the participants were young adults, allowing the assessment of the association between fat compartment and cardiovascular risk factors in the absence of significant comorbidities. Limitations of the study include two main facts. First, the fact that it did not use imaging methods to determine the visceral fat (CT, MRI and ultrasonography), due to the high cost of these methods; however, this equation has been previously validated to be used in young Brazilian women. Secondly, the study has a cross-sectional design; thus, the associations are not prospective and causality cannot be inferred.
The prevalence of visceral obesity found (30.6%) draws attention to the fact that it is a young female population, which usually has less fat in the visceral region, compared to older and male individuals. The study also shows that visceral fat was correlated with age and risk factors for development of CVD (SBP, DBP, TC, TG). The reduction of visceral fat may therefore contribute to a lower incidence of CVD in later life. More studies are needed to prospectively evaluate the impact of VAT reduction on the incidence of risk factors associated with metabolic syndrome and CVD.
Potential Conflict of Interest
No potential conflict of interest relevant to this article was reported.
Sources of Funding
This study was funded by CNPq.
This article is part of the thesis of Doctoral submitted by Marina de Moraes Vasconcelos Petribú, from Universidade Federal de Pernambuco.
1. Olinto MT, Nácul LC, Dias-da-Costa JS, Gigante DP, Menezes AM, Macedo S. Níveis de intervenção para obesidade abdominal: prevalência e fatores associados. Cad Saúde Pública. 2006; 22 (6): 1207-15. [ Links ]
2. Sampaio LR, Simões EJ, Assis AM, Ramos LR. Valididy and reliability of the sagittal abdominal diameter as a predictor of visceral abdominal fat. Arq Bras Endocrinol Metabol. 2007; 51 (6): 980-6. [ Links ]
3. Sandeep S, Gokulakrishnan K, Velmurugan K, Deepa M, Mohan V. Visceral & subcutaneous abdominal fat in relation to insulin resistance & metabolic syndrome in non-diabetic south Indians. Indian J Med Res. 2010; 131: 629-35. [ Links ]
4. Taksali SE, Caprio S, Dziura J, Dufour S, Calí AM, Robin Goodman T, et al. High visceral and low abdominal subcutaneous fat stores in the obese adolescent: a determinant of an adverse metabolic phenotype. Diabetes. 2008; 57(2): 367-71. [ Links ]
5. Demerath EW, Reed D, Rogers N, Sun SS, Lee M, Choh AC, et al. Visceral adiposity and its anatomical distribution as predictors of the metabolic syndrome and cardiometabolic risk factor levels. Am J Clin Nutr. 2008; 88 (5): 1263-71. [ Links ]
6. Romero-Corral A, Sert-Kuniyoshi FH, Sierra-Johnson J, Orban M, Gami A, Davison D, et al. Modest visceral fat gain causes endothelial dysfunction in healthy humans. J Am Coll Cardiol. 2010; 56 (8): 662-6. [ Links ]
7. Matsuzawa Y. Establishment of a concept of visceral fat syndrome and discovery of adiponectin. Proc Jpn Acad Ser B Phys Biol Sci.2010; 86 (2): 131-40. [ Links ]
8. Rankinen T, Kim SY, Pérusse L, Després JP, Bouchard C. The prediction of abdominal visceral fat level from composition and anthropometry: ROC analysis. Int J Obes Metab Disord. 1999;23(8):801-9. [ Links ]
9. Siegel MJ, Hildebolt CF, Bae KT, Hong C, White NH. Total and intraabdominal fat distribution in preadolescents and adolescents: measurement with MR Imaging. Radiology. 2007; 242 (3): 846-56. [ Links ]
10. Tadokoro N, Shinomiya M, Yoshinaga M, Takahashi H, Matsuoka K, Miyashita Y, et al. Visceral fat accumulation in Japanese high school students and related atherosclerosis risk factors. J Atheroscler Thromb. 2010; 17 (6): 546-57. [ Links ]
11. Piernas Sánchez CM, Morales Falo EM, Zamora Navarro S, Gauralet Aza M. Study and classification of the abdominal adiposity throughout the application of the wo-dimentional predictive equation Gauralet et al, in the clinical practice. Nutr Hosp. 2010; 25 (2): 270-4. [ Links ]
12. Nagai M, Komiya H, Mori Y, Ohta T. Developments in estimating visceral fat area from medical examination data. J Atheroscler Thromb. 2008; 15 (4): 193-8. [ Links ]
13. Brundavani V, Murthy SR, Kurpad. Estimation of deep-abdominal-adipose-tissue (DAAT) accumulation from simple anthropometric measurements in Indian men and women. Eur J Clin Nutr. 2006; 60(5): 658-66. [ Links ]
14. Ribeiro-Filho FF, Faria NA, Azjen S, Zanella MT, Ferreira SRG. Methods of estimation of visceral fat: advantages of ultrasonography. Obes Res. 2003; 11 (12): 1488-94. [ Links ]
15. Stolk RP, Wink O, Zelissen PM, Meijer R, Gils AP, Grobbee DE. Validity and reproducibility of ultrasonography for the measurement of intra-abdominal adipose tissue. Int J Obes Relat Metab Disord. 2001; 25(9): 1346-51. [ Links ]
16. Caballero B. The global epidemic of obesity: an overview. Epidemiol Rev. 2007; 29: 1-5. [ Links ]
17. World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO Consultation . World Health Organ Tech Rep Ser. 2000;894:i-xii, 1-255. [ Links ]
18. World Health Organization (WHO). Obesity: report WHO consultation on obesity. Geneva; 1998.p.7-15. [ Links ]
19. Haun DR, Pitanga FJG, Lessa I. Razão cintura/ estatura comparado a outros indicadores antropométricos de obesidade como preditor de risco coronariano elevado. Rev Assoc Med Bras. 2009; 55 (6):705-11. [ Links ]
20. Santos RD, Giannini S, Fonseca F, Moriguchi EH; Sociedade Brasileira de Cardiologia. III Diretrizes brasileiras sobre dislipidemias e diretriz de prevenção da aterosclerose do Departamento de Aterosclerose da Sociedade Brasileira de Cardiologia. Arq Bras Cardiol. 2001; 77 (supl.3):1-48. [ Links ]
21. American Diabetes Association. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 2010; 33 (1): S62-9. [ Links ]
22. Sociedade Brasileira de Cardiologia/Sociedade Brasileira de Hipertensão/ Sociedade Brasileira de Nefrologia. VI Diretrizes brasileiras de hipertensão arterial. Arq Bras Cardiol. 2010; 95 (1supl.):1-51. [ Links ]
23. Petribú MM. Equação preditiva para avaliação da gordura visceral em mulheres jovens. [tese]. Recife (PE): Universidade Federal de Pernambuco/ UFPE; 2011. [ Links ]
24. Hirooka M, Kumagi T, Kurose K, Nakanishi S, Michitaka K, Matsuura B, et al. A technique for the measurement of visceral fat by ultrasonograhy: comparison of measurements by ultrasonography and computed tomography. Intern Med. 2005; 44 (8): 794-9. [ Links ]
25. Onat A, Avci GS, Barlan MM, Uyarel H, Uzunlar B, Sansoy V. Measures of abdominal obesity assessed for visceral adiposity and relation to coronary risk. Int J Obes Relat Metab Disord. 2004; 28(8): 1018-25. [ Links ]
26. Pascot A, Lemieux S, Lemieux I, Prud´homme D, Tremblay A, Bouchard C, et al. Age-related increase in visceral adipose tissue and body fat and the metabolic risk profile of premenopausal women. Diabetes Care. 1999; 22 (9): 1471-8. [ Links ]
27. Flegal KM, Carrol MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999-2000. JAMA. 2002; 288(14): 1723-7. [ Links ]
28. Li C, Ford ES, McGuire LC, Mokdad AH. Increasing trends in waist circumference and abdominal obesity among US adults. Obesity (Silver Spring). 2007; 15(1): 216-24. [ Links ]
29. Pou KM, Massaro JM, Hoffmann U, Lieb K, Vasan R, O´Donnell CJ, et al. Patterns of abdominal fat distribution. Diabetes Care. 2009; 32 (3): 481-5. [ Links ]
30. Levy Y. It´s not only the overweight: it´s the visceral fat [editorial]. IMAJ. 2010; 12: 231-2. [ Links ]
31. Reyes M, Espinoza A, Rebollo MJ, Moraga F, Mericq V, Castillo-Duran C. Mediciones de adiposidad intraabdominal por ultrasonido y factores asociados com riesgo cardiovascular em niños obesos. Rev Med Chile. 2010; 138: 152-9. [ Links ]
32. Kotronen A, Yki-Järvinen H, Sevastianova K, Bergholm R, Hakkarainen A, Pietiläinen KH, et al. Comparison of the relative contributions of intra-abdominal and liver fat to components of the metabolic syndrome. Obesity. 2011; 19 (1): 23-8. [ Links ]
33. Vega GL. Is intra-abdominal obesity a unique risk factor for metabolic syndrome in non-diabetics? Indian J Med Res. 2010; 131: 603-5. [ Links ]
34. Santos CRB, Portella ES, Avila SS, Soares EA. Fatores dietéticos na prevenção e tratamento de co-morbidades associadas à síndrome metabólica. Rev Nutr. 2006; 19 (3): 389-401. [ Links ]
35. Hayes L, Pearce MS, Firbank MJ, Walker M, Taylor R, Unwin NC. Do obese but metabolically normal women differ in intra-abdominal fat and physical activity levels from those with the expected metabolic abnormalities? A cross-sectional study. BMC Public Health. 2010; 10: 723-31. [ Links ]
36. Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horvat P, Liu CY, et al. Abdominal visceral and subcutaneous adipose tissue compartments. Circulation. 2007; 116(1): 39-48. [ Links ]
Mailing Address: Manuscript received April 28, 2011; revised manuscript received April 28,
2011; accepted December 02, 2011.
Marina de Moraes Vasconcelos Petribú
Rua Professor José Brandão, 269 / 201 - Boa Viagem
51020-180 - Recife, PE - Brasil
Manuscript received April 28, 2011; revised manuscript received April 28, 2011; accepted December 02, 2011.